Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seulhee Kim

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Biological Engineering|May 3, 2019
Novel biomanufacturing platform for large-scale and high-quality human T cells productionJianfa Ou, Yingnan Si, Yawen Tang, et al.
Cancer Research|September 17, 2024
mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating CancerKai Chen, Patrick Ernst, Anusua Sarkar, et al.
Biotechnology Journal|October 10, 2019
Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and ValidationYingnan Si, Seulhee Kim, Eric Zhang, et al.
Pflugers Archiv : European Journal of Physiology|February 15, 2021
Investigation into the difference in mitochondrial-cytosolic calcium coupling between adult cardiomyocyte and hiPSC-CM using a novel multifunctional genetic probePatrick Ernst, Kai Chen, Yawen Tang, et al.
Biomedicines|January 23, 2024
Correction: Chen et al. Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. <i>Biomedicines</i> 2022, <i>10</i>, 130Kai Chen, Yingnan Si, Jia-Shiung Guan, et al.
Biomedicines|January 21, 2022
Targeted Extracellular Vesicles Delivered Verrucarin A to Treat GlioblastomaKai Chen, Yingnan Si, Jia-Shiung Guan, et al.
Pharmaceutics|January 21, 2022
Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast CancersYingnan Si, Kai Chen, Hanh Giai Ngo, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Antibody-Drug Conjugate to Treat MeningiomasKai Chen, Yingnan Si, Jianfa Ou, et al.
Cells|October 13, 2023
A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC)Jiashuai Zhang, Zhuoxin Zora Zhou, Kai Chen, et al.
Cancer Gene Therapy|July 21, 2020
Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapyYingnan Si, Seulhee Kim, Jianfa Ou, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Biological Engineering|May 3, 2019
Novel biomanufacturing platform for large-scale and high-quality human T cells productionJianfa Ou, Yingnan Si, Yawen Tang, et al.
Cancer Research|September 17, 2024
mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating CancerKai Chen, Patrick Ernst, Anusua Sarkar, et al.
Biotechnology Journal|October 10, 2019
Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and ValidationYingnan Si, Seulhee Kim, Eric Zhang, et al.
Pflugers Archiv : European Journal of Physiology|February 15, 2021
Investigation into the difference in mitochondrial-cytosolic calcium coupling between adult cardiomyocyte and hiPSC-CM using a novel multifunctional genetic probePatrick Ernst, Kai Chen, Yawen Tang, et al.
Biomedicines|January 23, 2024
Correction: Chen et al. Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. <i>Biomedicines</i> 2022, <i>10</i>, 130Kai Chen, Yingnan Si, Jia-Shiung Guan, et al.
Biomedicines|January 21, 2022
Targeted Extracellular Vesicles Delivered Verrucarin A to Treat GlioblastomaKai Chen, Yingnan Si, Jia-Shiung Guan, et al.
Pharmaceutics|January 21, 2022
Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast CancersYingnan Si, Kai Chen, Hanh Giai Ngo, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Antibody-Drug Conjugate to Treat MeningiomasKai Chen, Yingnan Si, Jianfa Ou, et al.
Cells|October 13, 2023
A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC)Jiashuai Zhang, Zhuoxin Zora Zhou, Kai Chen, et al.
Cancer Gene Therapy|July 21, 2020
Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapyYingnan Si, Seulhee Kim, Jianfa Ou, et al.
Pageof 3